Quasi-public venture capital firm Connecticut Innovations (CI) invested $15.1 million in 47 deals during the last quarter of 2021, the New Haven-based company announced Wednesday.
Of that sum, $5.7 million went to tech companies and $4.8 million went to healthcare companies, with the rest in sectors including climate tech and consumer goods.
The largest stakes went to Covr Financial Technologies, Tamarack Global, Halda Therapeutics, CytoVeris and Intellihealth.
New Haven-based Halda Therapeutics moved into renovated space at Winchester Works last year as part of an expansion.
CI’s funding leveraged an additional $112.6 million in outside capital, according to the company.
In the first two quarters of its 2022 fiscal year, CI invested a total of $22 million and leveraged $860 million.
CI Executive Vice President and Chief Investment Officer David Wurzer said, “Our portfolio companies continue to grow and raise the capital they need to be successful.”
In addition to CI’s investments, 100 angels invested $7.7 million across 33 Connecticut businesses through the Angel Investor Tax Credit program last year, CI reported.
Contact Liese Klein at lklein@newhavenbiz.com.
